CIK 0001580149
- Non-accelerated filer
- Smaller reporting company
BIOVIE INC.
Sign in to watch- Ticker
- BIVI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 462510769
- Phone
- +1 775-888-3162
- Business address
- 680 W NYE LANE, SUITE 201, CARSON CITY, NV, 89703
- Former names
- NANOANTIBIOTICS, INC.
Securities
- BIVI Common stock Nasdaq
- BIVIW Warrant Nasdaq
- 4 Derivatives Options or other derivatives
- 4 Grant or award Chief Financial Officer acquired 39,624 shares (grant or award)
- 4 Grant or award CEO & President acquired 79,248 shares (grant or award)
- 4 Grant or award EVP Liver Cirrhosis R&D acquired 39,624 shares (grant or award)
- 4 Grant or award Director acquired 16,380,096 shares (grant or award)
- 4 Grant or award Director acquired 3,636,364 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Gift EVP Liver Cirrhosis Programs gave 1,000 shares (gift)
- 4 Grant or award President & CEO acquired 21,710 shares (grant or award)
- 4 Open-market buy CFO bought 2,000 shares at $5.40 ($10,798)
- 3 Insider Initial Statement of Ownership
- 4 Gift EVP Liver Cirrhosis Programs gave 10,000 shares (gift)
Page 4 of 8 · 147 filings